Back to Journals » ClinicoEconomics and Outcomes Research » Volume 9

Budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trial [Corrigendum]

Total article views   HTML views PDF downloads Totals
6,855 Dovepress* 6,754+ 1,419 8,173
PubMed Central* 101 47 148
Totals 6,855 1,466 8,321
*Since 19 April 2017

View citations on PubMed Central and Google Scholar